Merck (MRK) Price to Sales (2009 - 2026)

Merck (MRK) has reported Price to Sales for 18 consecutive years, with 19.09 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Sales rose 52.61% year-over-year to 19.09 in Q2 2026; TTM through Jun 2026 was 4.76, a 53.23% increase from a year earlier, with the FY2025 full-year figure at 4.0, up 2.22% from the prior year.
• Price to Sales was 19.09 for Q2 2026 at Merck, up from 18.24 in the prior quarter.
• Over five years, Price to Sales peaked at 21.19 in Q1 2024 and troughed at 12.06 in Q3 2025.
• A 5-year average of 16.86 and a median of 16.79 in 2023 frame the typical range for Price to Sales.
• Across the five-year window, Price to Sales tumbled 35.77% in 2025 and soared 52.61% in 2026, its largest moves.
• Over 5 years, Price to Sales stood at 20.37 in 2022, then fell by 7.33% to 18.87 in 2023, then retreated by 14.78% to 16.08 in 2024, then slipped by 1.34% to 15.87 in 2025, then gained by 20.3% to 19.09 in 2026.
• The last three Price to Sales figures came in at 19.09 (Q2 2026), 18.24 (Q1 2026), and 15.87 (Q4 2025), per Business Quant data.